Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: reporting extended results from phase III clinical trials. National Multiple Sclerosis Society Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
UCSF/MT Zion Multiple Sclerosis Center, San Francisco, CA 95115, USA.
D E
DE
Goodkin
S
S
Reingold
W
W
Sibley
J
J
Wolinsky
H
H
McFarland
D
D
Cookfair
F
F
Lublin
D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic